Charles Patrick France

Affiliations: 
Pharmacology University of Texas Health Science Center at San Antonio, San Antonio, TX, United States 
Area:
Behavioral pharmacology
Google:
"Charles France"
Mean distance: 15.11 (cluster 19)
 
SNBCP
Cross-listing: Chemistry Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

France CP, Ahern G, Averick S, et al. (2020) Countermeasures for preventing and treating opioid overdose. Clinical Pharmacology and Therapeutics
Mada S, Gerak LR, Soyer A, et al. (2020) Behavioral effects of benzylideneoxymorphone (BOM), a low efficacy µ opioid receptor agonist and a δ opioid receptor antagonist. Psychopharmacology
Minervini V, Disney A, Husbands SM, et al. (2020) Methocinnamox (MCAM) antagonizes the behavioral suppressant effects of morphine without impairing delayed matching-to-sample accuracy in rhesus monkeys. Psychopharmacology
Maguire DR, France CP. (2020) Interactions between opioids and cannabinoids: Economic demand for opioid/cannabinoid mixtures. Drug and Alcohol Dependence. 212: 108043
Maguire DR, Gerak LR, Sanchez JJ, et al. (2020) Effects of acute and repeated treatment with methocinnamox, a mu opioid receptor antagonist, on fentanyl self-administration in rhesus monkeys. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Maguire DR, Gerak LR, Cami-Kobeci G, et al. (2019) OREX-1019: a novel treatment for opioid use disorder and relapse prevention. The Journal of Pharmacology and Experimental Therapeutics
Maguire DR, Minervini V, Dodda V, et al. (2019) Impact of order of fixed-ratio presentation on demand for self-administered remifentanil in male rats. Behavioural Pharmacology
Gerak LR, Maguire DR, France CP. (2019) Behavioral Pharmacology of Drugs Acting at Mu Opioid Receptors. Handbook of Experimental Pharmacology
Gerak LR, Minervini V, Latham E, et al. (2019) Methocinnamox (MCAM) produces long-lasting antagonism of the behavioral effects of µ opioid receptor agonists but not prolonged precipitated withdrawal in rats. The Journal of Pharmacology and Experimental Therapeutics
Collins GT, Sulima A, Rice KC, et al. (2019) Self-administration of the synthetic cathinones 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinopentiophenone (α-PVP) in rhesus monkeys. Psychopharmacology
See more...